The corporate VC arm invests in startups working at the intersection of food, agriculture, health and sustainability.
Category: Uncategorised
Hinz promoted to MD of Global Venture Lab
Niterra Group has promoted Daniel Hinz to managing director for its corporate venturing subsidiary, Global Venture Lab.
SoftBank to divest $2bn SoftBank Ventures Asia unit
Newly formed fund The Edgeof is set to acquire the $2bn SoftBank unit and expand its investment scope to cover the wider Asian region.
Deal Roundup: JSW One Platforms identifies $25m in funding
Mitsui provided $25m for JSW Group spinoff JSW One Platforms while RWE led a $15m round for clean energy system provider Ryse Energy.
Rising Stars 2023: Bonnie Chau
Bonnie Chau, principal at BCF Ventures, is one of our top 50 Rising Stars in corporate venturing in 2023.
Rising Stars 2023: Tyler Rowe
Tyler Rowe, principal at AEI HorizonX, is one of our top 50 Rising Stars in corporate venturing in 2023.
Emerging Leaders 2023: Daniel Wypler
Daniel Wypler, partner and global head of investments, QBE Ventures, is one of our emerging leaders in corporate venturing in 2023.
Rising Stars 2023: Michelle Zhou
Michelle Zhou, investment manager at Hyundai Cradle, is one of our top 50 Rising Stars in corporate venturing in 2023.
Automotive sensors: market overview
How many sensors does a modern-day car have? It is a simple question with a surprisingly tricky answer. The number can vary greatly anywhere from as little as 30 in somewhat dated vehicles to well over 200 in high-end modern ones. While cars have had sensors for some time, they are coming into a new… Continue reading Automotive sensors: market overview
Gareth Burns joins BP Ventures
The former head of Equinor Ventures joins bp ventures at a time of transition at the fund.
From consultancy to full CVC in three years — why Brazil’s Torq is moving fast
Torq Ventures — which has gone from consultancy to full CVC unit in 3 years — is a sign of how fast Brazilian corporate venture is growing.
Simplyhealth launches fund to invest in disease management
The UK health insurer says it is a good time to launch a fund as the froth has come out of valuations and “sensible” money can go in.
GVR Podcast: Should US CVCs worry about antitrust enforcement?
Antitrust is traditionally an M&A concern, but with the more aggressive approach that the Biden administration has taken towards enforcing antitrust laws, its implications are trickling down in a way CVCs in the US market can’t ignore. GCV senior reporter Kim Moore is back with us to talk about the rising antitrust scrutiny in the… Continue reading GVR Podcast: Should US CVCs worry about antitrust enforcement?
GVR Podcast: Applied Ventures’ approach to CVC 2.0
Anand Kamannavar joins GVR to speak about investing in public companies, looking ahead of the curve and having a great relationship with the corporate parent.